ライフサイエンスコーパス: prediabetes

1 >=65 years) and glycemic status (diabetes or prediabetes).

2 lanzapine, were overweight or obese, and had prediabetes.

3 n patients with HFrEF and type 2 diabetes or prediabetes.

4 ion and management of diabetes with focus on prediabetes.

5 d with greater IR and a higher likelihood of prediabetes.

6 ffecting multiple organs in individuals with prediabetes.

7 atio was also increased in these donors with prediabetes.

8 networks are affected in type 2 diabetes and prediabetes.

9 was attributable mainly to individuals with prediabetes.

10 rough compensation of insulin resistance, to prediabetes.

11 ldren with NAFLD also had type 2 diabetes or prediabetes.

12 ith overall diet quality in individuals with prediabetes.

13 parable among smokers and never-smokers with prediabetes.

14 .5% of the patients were women and 61.2% had prediabetes.

15 ection fraction <=40% and type 2 diabetes or prediabetes.

16 in UWS of patients with CP with and without prediabetes.

17 levated in patients with CP with and without prediabetes.

18 nd marginal bone loss (MBL) in patients with prediabetes.

19 have not specifically examined subsets with prediabetes.

20 ations, especially in those individuals with prediabetes.

21 flammatory conditions with gutka chewing and prediabetes.

22 individuals with prediabetes and 44 without prediabetes.

23 une T1D, whereas nondiabetic BBDP rats mimic prediabetes.

24 n in subjects with type 2 diabetes (T2D) and prediabetes.

25 er study involving 12 obese individuals with prediabetes.

26 dults with normal glucose tolerance and with prediabetes.

27 articipants with normal glucose tolerance or prediabetes.

28 ertain deleterious metabolic consequences of prediabetes.

29 nths, 13 (37%) had diabetes and 15 (43%) had prediabetes.

30 ticipants had diabetes, whereas 11 (42%) had prediabetes.

31 undiagnosed diabetes mellitus and 37.5% had prediabetes.

32 of diabetes in individuals with obesity and prediabetes.

33 ogression of early-stage type 2 diabetes and prediabetes.

34 1.78-2.46, p<0.0001) and for diabetes versus prediabetes 1.90 (1.65-2.17, p<0.0001).

35 (2.3%, 95% CI 0.4 to 4.2) than in those with prediabetes (1.2%, 0.0 to 2.4) or normoglycaemia (1.2%,

36 The most common new diagnoses were prediabetes (28 [6.1%]), vitamin B12 deficiency (20 [4.4

37 omen; 45 with normoglycemia [44.1%], 31 with prediabetes [30.4%], and 26 with type 2 diabetes [25.5%]

38 fetime risk was 48.7% (95% CI 46.2-51.3) for prediabetes, 31.3% (29.3-33.3) for diabetes, and 9.1% (7

39 f HCV RNA(+) 1.1%, of diabetes 10.5%, and of prediabetes 32.8%.

40 e with type 2 diabetes (43.2%) compared with prediabetes (34.2%) or normal glucose (22%) (P < .001).

41 ls to define undiagnosed diabetes (>/=6.5%); prediabetes (5.7% to 6.4%); and, among persons with diag

42 ) for central obesity, 30.5% (30.0-31.0) for prediabetes, 5.1% (4.9-5.3) for diabetes, 16.3% (15.9-16

43 indexes, were similar across groups: 69% had prediabetes, 54% had hypertension (47% were taking antih

44 In patients with prediabetes, 8-hour nightly CPAP treatment for 2 weeks i

45 nd Jan 1, 2012), 1148 participants developed prediabetes, 828 developed diabetes, and 237 started ins

46 nts with diabetes (16.4%) than in those with prediabetes (9.2%) or normoglycaemia (8.5%); hazard rati

47 c level was above guideline levels for DM or prediabetes according to the American Diabetes Associati

48 een peripheral hyperinsulinemia, as found in prediabetes, age-related neurodegeneration and cognitive

49 The prevalence ratio for prediabetes among participants with moderate/severe vs.

50 identify individuals with undiagnosed DM or prediabetes among patients attending a dental setting fo

51 alone in detecting dysglycemia (diabetes and prediabetes) among Asian women trying to conceive.

52 iabetes, and 38.0% (95% CI, 34.7%-41.3%) for prediabetes; among those with diabetes, 36.4% (95% CI, 3

53 re 0.97 (95% CI 0.87-1.09) for patients with prediabetes and 1.30 (95% CI 0.93-1.81) for those with n

54 ed hs-cTnT were 1.40 (95% CI, 1.08-1.80) for prediabetes and 2.47 (95% CI, 1.78-3.43) for diabetes me

55 fined using HbA1c values (29.2% vs 48.6% for prediabetes and 3.8% vs 7.3% for diabetes in 572 observa

56 e United States, 80 million individuals have prediabetes and 30 million have diabetes.

57 th is investigated among 44 individuals with prediabetes and 44 without prediabetes.

58 CI, 1.04-2.40) times greater odds of having prediabetes and 5.0 (95% CI, 2.49-9.98) times greater od

59 Ninety-five males (45 with prediabetes and 50 systemically healthy controls) were i

60 subjects who underwent MRI, 103 subjects had prediabetes and 54 had established diabetes.

61 %) did not have diabetes (of whom 10 344 had prediabetes and 6189 had normoglycaemia).

62 blind, placebo-controlled trial, adults with prediabetes and a body-mass index of at least 30 kg/m(2)

63 Prediabetes and Alzheimer's disease both increase in pre

64 imulated whole saliva (UWS) of patients with prediabetes and chronic periodontitis (CP) remains uninv

65 (USPSTF) recommended targeted screening for prediabetes and diabetes (dysglycemia) in adults who are

66 europathy is the most common complication of prediabetes and diabetes and presents as distal-to-proxi

67 uropathy progression and disease severity in prediabetes and diabetes correlates with dyslipidemia in

68 The global epidemic of prediabetes and diabetes has led to a corresponding epid

69 The substantial lifetime risk of prediabetes and diabetes in lean individuals also suppor

70 Here, we show that subjects with prediabetes and diabetes in the MetaCardis cohort from t

71 diastolic dysfunction among individuals with prediabetes and diabetes mellitus (versus diabetes melli

72 Persons with prediabetes and diabetes mellitus are at high risk for c

73 People with prediabetes and diabetes mellitus spend >50% of their ti

74 However, the relationships of prediabetes and diabetes mellitus to the development of

75 Prediabetes and diabetes mellitus were independently ass

76 ic simulation was developed to replicate the prediabetes and diabetes trends (1997-2010) in the U.S.

77 The prevalence of prediabetes and diabetes was statistically significantly

78 ANCE STATEMENT There is a global epidemic of prediabetes and diabetes, disorders that represent a con

79 of burn patients who may be at high risk of prediabetes and diabetes.

80 protect against coronary atherosclerosis in prediabetes and early diabetes mellitus among men.

81 flammation differed between individuals with prediabetes and healthy control participants.

82 T2D-related traits: risk of T2D, presence of prediabetes and homeostatic model of assessment - insuli

83 rovascular dysfunction is already present in prediabetes and is more severe in T2DM.

84 interventions, possible misclassification of prediabetes and metformin use, and inability to define e

85 etes, but were similar between patients with prediabetes and normoglycemia.

86 e (IR) and beta-cell function in people with prediabetes and suboptimal vitamin D status (<50 nmol/L)

87 le grain protects against the development of prediabetes and T2D and tested for modulation by polymor

88 NADPH levels were significantly degraded in prediabetes and T2D but were largely protected when mice

89 independently and inversely associated with prediabetes and T2D in Chinese adults.

90 to coordinate screening for and diagnosis of prediabetes and T2D.

91 es to T2D, and was inversely associated with prediabetes and T2D.

92 factors that are potentially manageable are prediabetes and the metabolic syndrome, neuropsychiatric

93 ncluding patients with diabetes mellitus and prediabetes and those with high risk of cardiovascular d

94 l blood glucose, particularly in people with prediabetes and type 1 and type 2 diabetes.

95 ss the associations of plasma magnesium with prediabetes and type 2 diabetes (T2D) among Chinese adul

96 8 in normal glucose metabolism, 3.0+/-2.7 in prediabetes, and 2.3+/-2.6 in T2DM.

97 icipants with diabetes, 47 participants with prediabetes, and 45 control participants underwent detai

98 ients (28.8%) had diabetes, 8246 (43.6%) had prediabetes, and 5234 (27.7%) had normoglycaemia.

99 in normal glucose metabolism, 1109+/-748 in prediabetes, and 937+/-683 in T2DM.

100 hewing alone, chewing among individuals with prediabetes, and chewing among healthy controls did not

101 ars among persons with no diabetes mellitus, prediabetes, and diabetes mellitus were 3.7%, 6.4%, and

102 Normoglycaemia, prediabetes, and diabetes were defined on the basis of W

103 anagement of humans with insulin resistance, prediabetes, and diabetes.

104 Patients with type 1 diabetes, prediabetes, and gestational diabetes were excluded.

105 Undiagnosed diabetes, prediabetes, and glucose control in persons with diagnos

106 fects in Patients With Diabetes Mellitus, or Prediabetes, and Heart Failure]) to investigate the card

107 Diabetes, prediabetes, and obesity are the likely metabolic driver

108 and insulin resistance in healthy controls, prediabetes, and T2D.

109 This resistance may be a stage of prediabetes, and the patients may develop hyperinsulinem

110 uxtamembrane epitopes, which appear early in prediabetes, and those to peptide 853-872 with Abs to an

111 mong subjects with normal glucose tolerance, prediabetes, and type 2 diabetes (P = .980).

112 munities Study with no diabetes mellitus, or prediabetes, and without cardiovascular disease includin

113 es; group 2: 30 patients with CP and without prediabetes; and group 3: 30 controls.

114 visits (aOR, 1.56; 1.22-1.99), and lifetime prediabetes (aOR, 1.71; 95% CI, 1.19-2.45).

115 Moreover, a large number of people with prediabetes are at risk for developing frank diabetes wo

116 Potential living kidney donors with prediabetes are often excluded from donation because of

117 estations of early disease in the context of prediabetes are poorly understood.

118 Among participants without baseline prediabetes, arsenic exposure was associated with incide

119 r fasting plasma glucose (FPG) >/=126 mg/dL, prediabetes as A1C 5.7%-<6.5% or FPG 100-<126 mg/dL, and

120 easures: The presence of type 2 diabetes and prediabetes as determined by American Diabetes Associati

121 en with NAFLD and assess type 2 diabetes and prediabetes as risk factors for nonalcoholic steatohepat

122 oping impaired glucose metabolism, including prediabetes, as are data for the risk of eventual progre

123 (95% CI: 1.18, 2.08) in participants without prediabetes at baseline.

124 lp identification of individuals with DM and prediabetes at early stages of disease, which may preven

125 yses showed a lower arteriolar %-dilation in prediabetes (B=-0.20, 95% confidence interval -0.56 to 0

126 usted analyses showed a lower %-hyperemia in prediabetes (B=-46 [-163 to 72]) with further deteriorat

127 Identification of DM and prediabetes based on a diagnosis of periodontitis yielde

128 mRNA/protein) were higher in AT derived from prediabetes BB rats with destructed pancreatic beta-cell

129 Prior to prediabetes, beta-cell function displays decreased stimu

130 h-fat diet (HFD) consumption caused not only prediabetes but also cognitive decline and brain patholo

131 progression from normal glucose tolerance to prediabetes by mechanisms likely tied to effects on insu

132 rms that individuals with undiagnosed DM and prediabetes can be identified in the dental office by ch

133 etabolic disease (ie, obesity, diabetes, and prediabetes) causes vascular dysfunction and is a risk f

134 tion of amylin is common in individuals with prediabetes, causes amylin deposition and proteotoxicity

135 HFD-fed rats exhibited prediabetes, cognitive decline, and brain pathologies.

136 Odds ratios (ORs) for diabetes and prediabetes, comparing persons with HCV infection to tho

137 g smokers and never-smokers with and without prediabetes (controls).

138 Prediabetes defined using the ADA fasting glucose concen

139 Prediabetes defined using the ADA HbA1c cutoff showed a

140 diovascular outcomes and death compared with prediabetes defined with glucose-based definitions.

141 We compared prediabetes definitions based on fasting glucose concent

142 the risk of future outcomes across different prediabetes definitions based on fasting glucose concent

143 Our results suggest that prediabetes definitions using HbA1c were more specific a

144 INTERPRETATION: Our results suggest that prediabetes definitions using HbA1c were more specific a

145 an inform the comparative value of different prediabetes definitions.

146 ity, hypertension, hypertension on 2 visits, prediabetes, diabetes, and high cholesterol than eczema

147 ontal pathogens influence the development of prediabetes/diabetes are not clear.

148 Notably, 32% of those with prediabetes/diabetes mellitus at 12 months postpartum ha

149 The prevalence of diabetes and prediabetes did not differ by HCV status.

150 -Western vitamin D-deficient immigrants with prediabetes did not improve insulin sensitivity or beta

151 dontal inflammation than individuals without prediabetes even after controlling for sex and gutka che

152 No consensus on definitions of prediabetes exists among international organisations.

153 A total of 130 non-Western immigrants with prediabetes (fasting glucose concentration >5.5 mmol/L o

154 at least two of three glycemic criteria for prediabetes (fasting plasma glucose level, 100 to 125 mg

155 o three groups: 1) group A: 75 patients with prediabetes (FBGLs = 100 to 125 mg/dL [HbA1c >/=5%]); 2)

156 he network measures of the participants with prediabetes fell between those with diabetes and control

157 Prediabetes (glucose based, 4.0%; hemoglobin A1c based,

158 ree groups: group 1: 28 patients with CP and prediabetes; group 2: 30 patients with CP and without pr

159 ting glucose (normoglycaemia: </=6.0 mmol/L; prediabetes: >6.0 mmol/L and <7.0 mmol/L; and diabetes >

160 Subjects with prediabetes had an increased risk for carotid plaque and

161 aphic adjustment, HbA1c-based definitions of prediabetes had higher hazard ratios and better risk dis

162 In addition, people with prediabetes had significantly elevated levels of PDFF an

163 exact relationship between periodontitis and prediabetes has not been established.

164 formin on cognition and brain pathologies in prediabetes have not been investigated.

165 glycaemia and diabetes risk in patients with prediabetes (HbA1c 5.7-6.4% [39-46 mmol/mol] or FPG 5.6-

166 was significantly greater among persons with prediabetes (HbA1c level of 5.7% to 6.4%) than among tho

167 led, 1856 (50%) had diabetes, 1268 (34%) had prediabetes (hemoglobin A1c [HbA1c] 5.7-6.4%), and 606 (

168 cose intolerance was defined as follows: (1) prediabetes: hemoglobin (HbA1c) >/=5.7 and <6.5% and (2)

169 Higher likelihood of prediabetes, higher HOMA-IR, and lower Matsuda index wer

170 HR 1.05, 0.94-1.17), including in those with prediabetes (HR 1.00, 0.89-1.13).

171 confounders (race, body mass index, diabetes/prediabetes, hypertension), adjusted cumulative odd rati

172 red in 86% (95% CI, 72 to 100), remission of prediabetes in 76% (95% CI, 56 to 97), remission of elev

173 of these parameters as well as the state of prediabetes in affected individuals.

174 ermine the prevalence of type 2 diabetes and prediabetes in children with NAFLD and assess type 2 dia

175 erence analysis investigating the effects of prediabetes in coronary artery disease, stroke and chron

176 -perceived oral symptoms among patients with prediabetes in group B and healthy controls.

177 cell compensation and insulin resistance in prediabetes in individuals with periodontitis.

178 valence of undiagnosed diabetes mellitus and prediabetes in patients with community-acquired pneumoni

179 to determine incident diabetes and prevalent prediabetes in survivors of critical illness experiencin

180 Several measurements were used to test for prediabetes, including fasting plasma glucose, insulin r

181 Diabetes and prediabetes increased risk of conversion from amnestic M

182 s of different lifestyle interventions among prediabetes individuals and to identify the optimal age

183 ed mitochondrial capacity is associated with prediabetes, IR, and duration and severity of hyperglyce

184 ere significantly higher in individuals with prediabetes irrespective of gutka-chewing habit (P <0.05

185 Prediabetes is a state of glycaemic dysregulation below

186 hough the observational studies suggest that prediabetes is broadly associated with diabetes complica

187 Whether prediabetes is causally related to diabetes complication

188 Identification of individuals with DM and prediabetes is important to reduce DM-related complicati

189 the causal inference analysis revealed that prediabetes is only causally related with coronary arter

190 tal inflammatory parameters in patients with prediabetes is unknown.

191 In conclusion, prediabetes likely causes coronary artery disease and it

192 T2DM, but also prediabetes, may be risk factors for prefrontal neuroche

193 erm intervention study in 3234 subjects with prediabetes (mean+/-SD age, 64+/-10 years) that showed r

194 3%) male, 82 (78.1%) diabetes and 23 (21.9%) prediabetes, mean LV ejection fraction 32.5% (9.8%), and

195 a levels of selected miRNAs in subjects with prediabetes (n = 12), type 2 diabetes (T2D, n = 31), lat

196 rmal glucose tolerance (n = 740), those with prediabetes (n = 431), and those with confirmed type 2 d

197 th normal glucose tolerance (NGT) (n = 774), prediabetes (n = 525), or screen-detected type 2 diabete

198 (n = 5), 29% in the obese participants with prediabetes (n = 9), and 34.6% in the obese participants

199 ce test; normal glucose metabolism [n=1269], prediabetes [n=335], or T2DM [n=609]).

200 classified into four groups: normoglycaemia, prediabetes, newly diagnosed diabetes, and known diabete

201 nonalcoholic fatty liver disease (NAFLD) and prediabetes (obese-NAFLD; n = 22).RESULTSInsulin sensiti

202 Diabetes and prediabetes occur frequently in survivors of ICU experie

203 Prediabetes (odds ratio, 3.82; 95% CI, 0.95-15.41) was n

204 Globally, ~352 million people have prediabetes, of which 35-50% develop full-blown diabetes

205 Currently, the impact of diabetes and prediabetes on cognition and the underlying organization

206 f intermediate hyperglycaemia (also known as prediabetes) on the basis of their ability to predict wh

207 e were estimated as the number of years from prediabetes onset and the average oral glucose tolerance

208 eas islet mass continues to increase through prediabetes onset.

209 moglycemic participants and individuals with prediabetes or diabetes (n = 8/group).

210 the C24:0 ceramide only in individuals with prediabetes or diabetes (Ptrend = 0.001).

211 presence of pancreatic fat is not related to prediabetes or diabetes, which suggests that it has litt

212 rtment were observed in children with either prediabetes or diabetes.

213 Participants with prediabetes or newly diagnosed diabetes had similar rate

214 iflozin did not lower HbA1c in patients with prediabetes or normoglycemia and was not associated with

215 of the drug did not differ in patients with prediabetes or normoglycemia.

216 enance sessions, risk level of participants (prediabetes or other), and intervention delivery personn

217 lesterol, in overweight or obese people with prediabetes or T2D.

218 risk to deteriorate in glucose tolerance (to prediabetes or T2D; women and men combined).

219 Patients (n = 101) with prediabetes or T2DM and biopsy-proven NASH were recruite

220 tment is safe and effective in patients with prediabetes or T2DM and NASH.

221 onse to an OGTT, and both men and women with prediabetes or type 2 diabetes had 16-21% lower 120-min

222 mpared with individuals with NGT, women with prediabetes or type 2 diabetes had 25% lower GLP-1 respo

223 s of nonalcoholic steatohepatitis (NASH) and prediabetes or type 2 diabetes mellitus (T2DM) seem to b

224 5.7% [39 mmol/mol]); (2) diagnosis codes for prediabetes or type 2 diabetes; or (3) antidiabetic medi

225 outcomes (hypertension, composite diabetes [prediabetes or type 2 diabetes], hyperlipidemia, cardiov

226 I-based; OR = 2.37, p = 0.001, waist-based), prediabetes (OR = 1.55, p = 0.02), diabetes (OR = 1.72,

227 NASH were significantly higher in those with prediabetes (OR, 1.9; 95% CI, 1.21-2.9) or type 2 diabet

228 f individuals who did not have diabetes, had prediabetes, or had diabetes.

229 s by glycaemic status at baseline (diabetes, prediabetes, or normoglycaemia)-defined on the basis of

230 groups over time in patients with diabetes, prediabetes, or normoglycaemia.

231 s BP in individuals with insulin resistance, prediabetes, or other noncommunicable chronic diseases.

232 106 healthy individuals and individuals with prediabetes over approximately four years and performed

233 that beta-cell compensation associated with prediabetes overlaps with, and negates, its proliferativ

234 gher frequencies of hypertriglyceridemia and prediabetes (p < 0.005, p = 0.023 respectively).

235 gher among controls than among patients with prediabetes (P <0.05).

236 riglycerides (p = 0.015) and higher rates of prediabetes (p = 0.004), while LRRK2-NMC had higher trig

237 control analysis of 4447 867 newly diagnosed prediabetes patients, 1475 newly diagnosed T2D patients

238 on among patients with diabetes mellitus and prediabetes, patients at high risk of cardiovascular dis

239 Associations were significant for prediabetes per se (all, OR: 0.73; 95% CI: 0.56, 0.94; m

240 Among patients with prediabetes, periodontal inflammation and whole salivary

241 le modification, irrespective of whether the prediabetes phenotype is defined by hyperglycaemia in th

242 Metabolic syndrome and prediabetes predicted all-cause dementia in people with

243 Modified Poisson regression evaluated prediabetes prevalence across bacterial tertiles.

244 association between periodontal bacteria and prediabetes prevalence among diabetes-free adults.

245 dontal microbiota are associated with higher prediabetes prevalence among diabetes-free adults.

246 Prediabetes prevalence was 18%, and 58% of participants

247 Prediabetes prevalence was 42%, and diabetes mellitus pr

248 anagement, people with diabetes mellitus and prediabetes remain at increased coronary heart disease r

249 a and IL-6 in smokers and never-smokers with prediabetes remains uninvestigated.

250 flammation in gutka chewers with and without prediabetes remains unknown.

251 ave undiagnosed type 2 diabetes mellitus and prediabetes, respectively.

252 corresponding to guideline levels for DM and prediabetes, respectively.

253 t could enhance population-wide diabetes and prediabetes screening strategies.

254 Thus, subjects with prediabetes show early signs of subclinical disease that

255 with transient insulin resistance during the prediabetes stage and then underwent rapid beta-cell los

256 The prediabetes stage was prolonged in the hemizygous mice,

257 ars consistently reduced at the asymptomatic prediabetes stage, including in db/db mice, showing stro

258 unctional beta-cell mass in the asymptomatic prediabetes stage.

259 s relationship in humans using data from the prediabetes study of the Integrated Human Microbiome Pro

260 Prediabetes, T2DM, and measures of hyperglycemia are ind

261 o do so, we investigated the associations of prediabetes, T2DM, and measures of hyperglycemia with mi

262 0.05) levels were higher among patients with prediabetes than controls.

263 rameters, and MBL are worse in patients with prediabetes than controls.

264 function in glucose metabolism in youth with prediabetes, the relationship between adipose tissue ins

265 rs compared to non-chewers; in patients with prediabetes, the severity of periodontal inflammation is

266 In participants with undiagnosed prediabetes, the use of health claims alone, of both lab

267 olerable, evidence-based, and cost-effective prediabetes therapy.

268 -artery dysfunction, which already occurs in prediabetes ("ticking clock hypothesis").

269 ta for the risk of eventual progression from prediabetes to diabetes and for initiation of insulin tr

270 45 years, the lifetime risk to progress from prediabetes to diabetes was 74.0% (95% CI 67.6-80.5), an

271 imated the lifetime risk of progression from prediabetes to overt diabetes and from diabetes free of

272 Plasma magnesium decreased from NGT to prediabetes to T2D, and was inversely associated with pr

273 e 3-year assessment of the SCALE Obesity and Prediabetes trial we aimed to evaluate the proportion of

274 glucose impairments, from normoglycaemia to prediabetes, type 2 diabetes, and eventual insulin use.

275 In conclusion, early in the development of prediabetes/type 2 diabetes in youth, ChREBPbeta express

276 We aimed to determine the prevalence of prediabetes, undiagnosed diabetes mellitus, and risk fac

277 The definition of prediabetes using the ADA fasting glucose concentration

278 mice, we modeled metabolic disease (obesity/prediabetes) via chronic high-fat (HF) diet and modeled

279 nic (445 of 675).The estimated prevalence of prediabetes was 23.4% (95% CI, 20.2%-26.6%), and the est

280 Prediabetes was defined as a hemoglobin A1c level of 5.7

281 Prediabetes was defined as follows: 1) hemoglobin A1c va

282 Prediabetes was defined using the American Diabetes Asso

283 valence of undiagnosed diabetes mellitus and prediabetes was estimated based on hemoglobin A1c measur

284 The prevalence of prediabetes was lower when defined by calibrated HbA1c l

285 G, or 2-hour PG definitions for diabetes and prediabetes) was 14.3% (95% CI, 12.2%-16.8%) for total d

286 etabolism.Among African-American adults with prediabetes, we conducted a double-blinded pilot randomi

287 ng associations between bacterial levels and prediabetes were as follows: A. actinomycetemcomitans, 2

288 Glucose tolerance status and prediabetes were defined according to the American Diabe

289 All patients with prediabetes were hyperglycemic.

290 While elevated triglycerides and prediabetes were more frequent among LRRK2 carriers, MS

291 Effect estimates for individuals with prediabetes were much larger and highly statistically si

292 periodontal inflammation in individuals with prediabetes were nine times higher than in healthy contr

293 portions of patients with undiagnosed DM and prediabetes were observed in the periodontitis group (32

294 Only 3.7% of patients with prediabetes were prescribed metformin over the 3-year st

295 Individuals with prediabetes were significantly more likely to have perio

296 Twenty-seven controls and 29 patients with prediabetes were smokers.

297 al data from 2654 US adults with undiagnosed prediabetes who participated in the 2005-2010 NHANES cyc

298 evaluate the proportion of individuals with prediabetes who were diagnosed with type 2 diabetes.

299 Percentage of health plan enrollees with prediabetes who were prescribed metformin.

300 ed for possible associations of diabetes and prediabetes with cognitive decline.